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Risk factors for stroke in Tanzania
Stroke is a leading cause of death and disability 
worldwide, mandating the need for a global strategy 
for stroke prevention.1–3 Central to the development of 
a strategy for stroke prevention is the need to establish 
the importance of modiﬁ able risk factors for stroke, 
both globally and within regions and countries. Whereas 
the age-adjusted incidence of stroke is decreasing in 
high-income countries, it is increasing in low-income 
and middle-income countries.4
Until recently, our knowledge of risk factors for stroke 
was derived almost exclusively from western Europe 
and North America. Phase 1 of the INTERSTROKE 
study,3 which assessed the importance of risk factors 
in 22 high-income, middle-income, and low-income 
countries, reported that 90% of the population-
attributable risk for stroke was associated with ten risk 
factors: hypertension, smoking, physical inactivity, 
poor diet, obesity, dyslipidaemia, diabetes mellitus, 
psychosocial stress, depression, and cardiac causes 
(eg, atrial ﬁ brillation). Despite inclusion of 3000 cases 
and 3000 controls, this study was not large enough to 
reliably assess whether there were important regional 
variations in the eﬀ ect of risk factors. Such information 
is essential to implement region-speciﬁ c population-
based interventions to reduce the burden of stroke. 
The full-scale INTERSTROKE study, which now includes 
more than 26 000 participants from 31 countries, and 
which is expected to be reported in 2014, will provide 
reliable estimates of the importance of risk factors for 
stroke (both overall and by subtype) in diﬀ erent regions 
of the world. Regional variations in the importance 
of risk factors for stroke might relate to variations in 
the prevalence or strength of association of common 
risk factors, or to the presence of unique risk factors in 
some regions or populations (eg, speciﬁ c infections or 
rheumatic heart disease).5
In The Lancet Global Health, Richard Walker and 
colleagues6 report the results of a case-control study 
of risk factors for stroke in Tanzania. Their study makes 
several important contributions. First, they provide 
the ﬁ rst information about importance of risk factors 
for stroke in urban and rural Tanzania, and conﬁ rm the 
feasibility of undertaking challenging stroke research in 
a low-income setting, for which the investigators should 
be congratulated. A key challenge in stroke research is 
identiﬁ cation of stroke subtype, because even the major 
distinction between ischaemic and haemorrhagic stroke 
requires neuroimaging, which is not completed in 
many patients in low-income settings because of poor 
availability and access and high costs. Neuroimaging is 
also required for exclusion of some non-stroke causes. In 
Walker and colleagues’ study, less than half of patients 
underwent CT scans of the brain.
Second, the investigators report the importance 
of known modiﬁ able risk factors for stroke, of which 
hypertension, smoking, and hypercholesterolaemia 
were the most important. The prevalence of 
hypertension in cases and controls was very high, 
making it a key modiﬁ able risk factor for stroke 
in Tanzania. Country-speciﬁ c and region-speciﬁ c 
information about risk factors for stroke is an essential 
step for raising of local awareness to inform health 
policy, even when information about some risk factors, 
such as hypertension, is largely conﬁ rmatory. The risk 
associated with dyslipidaemia (odds ratio 4·54, 95% CI 
2·49–8·28) was higher than that reported in previous 
epidemiological studies,3,7 which might suggest that 
this disorder could be a greater risk factor in Africa 
than in other regions; however, this notion requires 
conﬁ rmation in larger studies. The study did not obtain 
data for diet, physical activity, or obesity, which are also 
likely to be important. 
Third, Walker and colleagues provide information 
about emerging risk factors for stroke, which might 
have importance for speciﬁ c approaches to prevent 
stroke in Tanzania. In this regard, the importance of 
HIV infection is a notable ﬁ nding, and associated with 
a increase of ﬁ ve times in risk of stroke, which is larger 
than that reported in previous studies.8–10 However, 
HIV status was missing in 44% of the cohort and the 
methods of case recruitment might have introduced a 
selection bias for this risk factor. Furthermore, because 
only 40% of cases underwent neuroimaging, non-
stroke causes might have been included among cases. 
Nevertheless, these ﬁ ndings are provocative, and should 
prompt future studies to examine this important issue 
in larger studies.
If these studies conﬁ rm the association of HIV 
with stroke, studies to better understand the 
pathophysiology of why HIV increases stroke risk and 
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speciﬁ c interventions to reduce the risk will be needed. 
In the meantime, more vigorous eﬀ orts at control of 
hypertension, treatment of dyslipidaemia, and tobacco 
control should be the main focus of strategies to reduce 
the bur den of stroke in Africa. In parallel, eﬀ orts to 
control the HIV epidemic should continue.
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